← Back to Search

Prenatal Exercise for Newborn Cognitive Development

N/A

Waitlist Available

Led By Elise L.LeMoyne

Research Sponsored by Université de Montréal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

20 to 35 years of age

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial will study the effects of exercising during pregnancy on the brain development of newborns. Sixty pregnant women will be randomly assigned to either an exercise or control group. The exercise group will be asked to exercise for at least 20 minutes, 3 times per week. Newborns' brain activity will be recorded using electroencephalography (EEG) 10 days after they are born. The primary outcome measure will be the amplitude and latency of the mismatch negativity (MMN), a component of the auditory event-related potential (ERP).

Who is the study for?

This trial is for healthy first-time pregnant women aged 20-35, with a normal pre-pregnancy BMI (18-25), taking folic acid and without health issues. They must not use alcohol, cigarettes or illegal drugs, have pregnancy complications, or excessive/inadequate weight gain.Check my eligibility

What is being tested?

The study tests if exercising during pregnancy at least 20 minutes three times a week improves the newborn's brain development. This is measured by EEG to check the baby's auditory sensory memory 10 days after birth compared to babies of non-exercising mothers.See study design

What are the potential side effects?

Since this trial involves regular exercise which is generally safe during pregnancy when done correctly, no specific side effects are expected for the interventions being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 20 and 35 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mismatch negativity

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ExerciseExperimental Treatment1 Intervention

Group II: ControlActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exercise

2016

Completed Phase 1

~760

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Université de MontréalLead Sponsor

213 Previous Clinical Trials

102,721 Total Patients Enrolled

Elise L.LeMoynePrincipal InvestigatorUniversité de Montréal

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT01220778 — N/A

Pregnancy Research Study Groups: Exercise, Control

Pregnancy Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT01220778 — N/A

Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT01220778 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals below the age of 35 permitted to participate in this scientific experiment?

"This medical research requires that participants between the ages of 20 and 35 are eligible to take part. There are 21 trials with age limits set below 18 years old, while 34 studies have been established for people aged over 65."

Answered by AI